Stock Quotes & Company News | Reuters.com
Edition:
United States

People: Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

1.84USD
29 Jun 2016
Change (% chg)

$0.04 (+2.22%)
Prev Close
$1.80
Open
$1.81
Day's High
$1.86
Day's Low
$1.81
Volume
1,034
Avg. Vol
31,797
52-wk High
$4.95
52-wk Low
$1.61

Skelly, William 

Mr. William G. Skelly is an Independent Director of Acura Pharmaceutical Technologies, Inc. since May 1996 and served as our Chairman from October 1996 through June 2000. Since 1990, Mr. Skelly has served as Chairman, President and Chief Executive Officer of Central Biomedia, Inc. and its subsidiary SERA, Inc. From 1985 to 1990, Mr. Skelly served as President of Martec Pharmaceutical, Inc. Mr. Skelly earned a Bachelor of Arts degree from Michigan State University and a Masters of Business Administration from the University of Missouri-Kansas City.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Jones

503,424

Peter Clemens

363,160

Robert Seiser

196,948

J. Bradley Rivet

209,422

Albert Brzeczko

351,528

James Emigh

196,948
As Of  30 Dec 2014